18 months into the first serious clinical trials of CRISPR gene therapy for sickle cell disease and beta-thalassemia—and all patients are free from symptoms and have not needed blood transfusions. Sickle cell disease (SCD) can cause a variety of health problems including episodes of severe pain, called vaso-occlusive crises, as well as organ damage and […]
The post Every Patient Treated With CRISPR Gene Therapy for Blood Diseases Continues to Thrive, More Than a Year On appeared first on Good News Network.
18 months into the first serious clinical trials of CRISPR gene therapy for sickle cell disease and beta-thalassemia—and all patients are free from symptoms and have not needed blood transfusions. Sickle cell disease (SCD) can cause a variety of health problems including episodes of severe pain, called vaso-occlusive crises, as well as organ damage and
The post Every Patient Treated With CRISPR Gene Therapy for Blood Diseases Continues to Thrive, More Than a Year On appeared first on Good News Network.